TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Diamyd Medical AB
Closing information (x1000 NOK)
| Closing information | 2024/08 (consolidated) | 2023/08 (consolidated) | 2022/08 (consolidated) |
| Turnover |
134
|
533
|
418 |
| Financial expenses |
12,266
|
3
|
233 |
| Earnings before taxes |
-156,224
|
-113,204
|
-95,214 |
| EBITDA |
-139,481
|
-113,072
|
-104,666 |
| Total assets |
223,289
|
200,722
|
217,552 |
| Current assets |
163,728
|
137,329
|
159,134 |
| Current liabilities |
41,179
|
19,363
|
19,653 |
| Equity capital |
150,123
|
165,210
|
197,184 |
| - share capital |
10,405
|
8,485
|
7,176 |
| Employees (average) |
25
|
22
|
0 |
Financial ratios
| Fiscal year | 2024/08 (consolidated) | 2023/08 (consolidated) | 2022/08 (consolidated) |
| Solvency |
67.2%
|
82.3%
|
90.6% |
| Turnover per employee |
5
|
24 | |
| Profit as a percentage of turnover |
-116585.1%
|
-21239.0%
|
-22778.5% |
| Return on assets (ROA) |
-64.5%
|
-56.4%
|
-43.7% |
| Current ratio |
397.6%
|
709.2%
|
809.7% |
| Return on equity (ROE) |
-104.1%
|
-68.5%
|
-48.3% |
| Change turnover |
-428
|
90
|
185 |
| Change turnover % |
-76%
|
20% | |
| Chg. No. of employees |
3
|
22
|
-14 |
| Chg. No. of employees % | 14% |
Total value of public sale
| Fiscal year | 2024/08 (consolidated) | 2023/08 (consolidated) | 2022/08 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.